A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab

Objectives: IgG4-related disease (IgG4-RD) is a chronic fibro-inflammatory disorder affecting virtually any organ. Type 1 autoimmune (type 1 AIP) is its pancreatic manifestation. To date, steroids are considered the first-line pancreatitis treatment. The CD20-binding antibody rituximab (RTX) appears...

Descripción completa

Detalles Bibliográficos
Autores principales: Backhus, Johanna, Neumann, Christian, Perkhofer, Lukas, Schulte, Lucas A, Mayer, Benjamin, Seufferlein, Thomas, Müller, Martin, Kleger, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004657/
https://www.ncbi.nlm.nih.gov/pubmed/33807051
http://dx.doi.org/10.3390/jcm10061329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004657/
https://www.ncbi.nlm.nih.gov/pubmed/33807051
http://dx.doi.org/10.3390/jcm10061329

Ejemplares similares